Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|June 5, 2013
Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritisLuis Aguilar-Lozano, Jose Dionisio Castillo-Ortiz, Cesar Vargas-Serafin, et al.
Arthritis and Rheumatism|April 9, 2005
Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled studyDésirée van der Heijde, Herbert S B Baraf, Cesar Ramos-Remus, et al.
Clinical Rheumatology|July 25, 2007
Latitude gradient influences the age of onset in rheumatoid arthritis patientsCesar Ramos-Remus, Gabriela Sierra-Jimenez, Kenneth Skeith, et al.
International Journal of Immunogenetics|January 26, 2019
Evaluation of SUMO1 and POU2AF1 in whole blood from rheumatoid arthritis patients and at risk relativesMaria Fernanda Romo-García, Hilda Susana Nava-Ramírez, Martin Zapata-Zúñiga, et al.
Clinical Rheumatology|October 12, 2013
The number needed to offend: a cross-sectional study of potential offensiveness of rheumatic diagnostic labelsJosé Dionisio Castillo-Ortiz, Anthony S Russell, Paul Davis, et al.
Seminars in Arthritis and Rheumatism|May 5, 2018
Trends of Informed Consent forms for industry-sponsored clinical trials in rheumatology over a 17-year period: Readability, and assessment of patients' health literacy and perceptionsHector de la Mora-Molina, Aldo Barajas-Ochoa, Leon Sandoval-Garcia, et al.
Human Immunology|July 22, 2020
Subclinical inflammation in the preclinical phase of rheumatoid arthritis might contribute to articular joint damageMariela Gomez-Moreno, Elsy Janet Ramos-González, Julio Enrique Castañeda-Delgado, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the diseaseCesar Ramos-Remus, Jose Dionisio Castillo-Ortiz, Luis Aguilar-Lozano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2016
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug TreatmentRoy Fleischmann, Michael Schiff, Désirée van der Heijde, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2025
Novel RSAD2 isoforms lacking antiviral activities are originated from alternative splicing and expressed in patients with rheumatic diseasesMariela Gómez-Moreno, Rosalinda Najera-Lerma, Jaquelin Partida-Lozano, et al.
Pageof 5